amsacrine

Small moleculeexperimental

Clinical trial activity

10 trials · 16 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
8
Phase 3
6
Phase 4
1

Earliest trial started Nov 1, 1986 (NCT01324063)

Timeline

1980s

  1. Jan 1, 1986

    Earliest Phase 3 Sponsor(trial)

2000s

  1. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12
Mol. weight
393.47 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Parenteral

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • 4'-(9-acridinylamino)-3'-methoxymethanesulfonanilide
  • 4'-(9-acridinylamino)-3'-methoxymethanesulfonanilide
  • 4'-(9-acridinylamino)methanesulfon-m-anisidide
  • 4'-(9-acridinylamino)methanesulfon-m-anisidide
  • 4'-(9-acridinylamino)methanesulfon-meta-anisidide
  • 4'-(9-acridinylamino)methanesulfon-meta-anisidide
  • 4'-(9-acridinylamino)methanesulphon-m-anisidide
  • 4'-(9-acridinylamino)methanesulphon-m-anisidide
  • acridinylanisidide
  • acridinyl anisidide
  • acridinyl anisidide
  • amekrin
  • amsacrine
  • amsacrine
  • amsacrine
  • amsacrine
  • amsacrine
  • amsacrine
  • amsacrine
  • amsacrine
  • amsidil
  • amsidine
  • amsidyl
  • amsidyl
  • amsidyl
  • ci-880
  • ci-880
  • lamasine
  • mamsa
  • mamsa
  • m-amsa
  • m-amsa
  • m-amsa
  • nci-249992

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05807932Phase 1/Phase 2 (Phase 2)Jun 26, 2023University of Duesseldorf
NCT03765541Phase 3Sep 30, 2019University of Toulouse
NCT01423175Phase 2Jul 1, 2011Genzyme, Gottfried Wilhelm Leibniz Universität Hannover, Hannover Clinical Trial Center GmbH
NCT01228331Phase 2/Phase 3 (Phase 3)Oct 1, 2010University of Hamburg
NCT00840684Phase 1/Phase 2 (Phase 2)Jan 1, 2009Institut Paoli-Calmettes
NCT00180102Phase 4Dec 1, 2003Technical University of Dresden
NCT00003436Phase 3Jul 1, 1998Medical Research Council, The Christie NHS Foundation Trust
NCT00002719Phase 3Dec 1, 1995European Organisation for Research and Treatment of Cancer, Gruppo Italiano Malattie EMatologiche dell'Adulto, Leiden University, University of Roma La Sapienza
NCT00002658Phase 3Jan 1, 1994Cardiff University, Medical Research Council
NCT01324063Phase 3Nov 1, 1986European Organisation for Research and Treatment of Cancer, University of Paris
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (16)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
European Organisation for Research and Treatment of CancerAcademic/Hospital2211986
Medical Research CouncilGovernment2211994
Cardiff UniversityAcademic/Hospital1011994
GenzymeFor profit1012011
Gottfried Wilhelm Leibniz Universität HannoverAcademic/Hospital1112011
Gruppo Italiano Malattie EMatologiche dell'AdultoAcademic/Hospital1011995
Hannover Clinical Trial Center GmbHFor profit1012011
Institut Paoli-CalmettesAcademic/Hospital1112009
Leiden UniversityAcademic/Hospital1011995
Technical University of DresdenAcademic/Hospital1112003
The Christie NHS Foundation TrustAcademic/Hospital1011998
University of DuesseldorfAcademic/Hospital1112023
University of HamburgAcademic/Hospital1112010
University of ParisAcademic/Hospital1011986
University of Roma La SapienzaAcademic/Hospital1011995
University of ToulouseAcademic/Hospital1112019
16 organizations
Page 1 / 1